Targeted mydriasis strategies for diabetic retinopathy screening clinics
نویسندگان
چکیده
منابع مشابه
Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device
Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults. Therefore, it is important to detect DR accurately during mass screening. The purpose of this study was to determine whether a small, hand-held, mydriasis-free, full-field flicker electroretinographic (ERGs) device called RETeval can be used to screen for DR. To accomplish this, we recorded full-field flicker ER...
متن کاملScreening for Diabetic Retinopathy
D iabetic retinopathy is a highly specific vascular complication of both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes mellitus. The prevalence of retinopathy is strongly related to the duration of diabetes. After 20 yr of diabetes, nearly all patients with type I diabetes and >60% of patients with type II diabetes have some degree of retinopathy. Diabetic retinopathy ...
متن کاملScreening for diabetic retinopathy.
In this issue, Malone et al. (1) use their analysis of the retinal photographs taken in the Diabetes Control and Complications Trial (DCCT) to try to challenge the well-established dictum that it is not useful to perform early screening (,5 years duration) for diabetic retinopathy in juvenile-onset type 1 diabetes. I share their enthusiasm for preventing vision loss; however, in my judgment, th...
متن کاملDiabetic Retinopathy AMERICAN DIABETES ASSOCIATION SCREENING FOR DIABETIC RETINOPATHY
SCREENING FOR DIABETIC RETINOPATHY — Diabetic retinopathy is a highly specific vascular complication of both type 1 and type 2 diabetes. The prevalence of retinopathy is strongly related to the duration of diabetes. After 20 years of diabetes, nearly all patients with type 1 diabetes and 60% of patients with type 2 diabetes have some degree of retinopathy. Diabetic retinopathy poses a serious t...
متن کاملDiabetic retinopathy screening update
Diabetic retinopathy is the leading cause of blindness among adults aged 20–74 years in the United States, which notably includes the working-age population. With early detection, diabetic retinopathy can be treated with modalities that have been proven to decrease the risk of severe vision loss by > 90%. Given the proven benefits of early detection, guidelines for screening for diabetic retino...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Eye
سال: 2010
ISSN: 0950-222X,1476-5454
DOI: 10.1038/eye.2009.338